Pieris napi chromosome 19, ilPieNapi1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Lepidoptera; Glossata; Ditrysia; Papilionoidea; Pieridae; Pierinae; Pieris.
REFSEQ INFORMATION: The reference sequence is identical to\nFR997713.1.\nAssembly name: ilPieNapi1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/01/30. The original whole-genome shotgun project has the\naccession CAJQFT000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Pieris napi Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 130 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
solute carrier family 41 member 1-like, transcript variant X2
solute carrier family 41 member 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon AAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
solute carrier family 41 member 1-like isoform X1
solute carrier family 41 member 1-like, transcript variant X3
solute carrier family 41 member 1-like isoform X2
plasma membrane calcium-transporting ATPase 3, transcript variant X2
plasma membrane calcium-transporting ATPase 3, transcript variant X4
plasma membrane calcium-transporting ATPase 3, transcript variant X9
plasma membrane calcium-transporting ATPase 3, transcript variant X3
plasma membrane calcium-transporting ATPase 3, transcript variant X1
plasma membrane calcium-transporting ATPase 3, transcript variant X7
plasma membrane calcium-transporting ATPase 3, transcript variant X11
plasma membrane calcium-transporting ATPase 3, transcript variant X10
plasma membrane calcium-transporting ATPase 3, transcript variant X13
plasma membrane calcium-transporting ATPase 3, transcript variant X14
plasma membrane calcium-transporting ATPase 3, transcript variant X12
plasma membrane calcium-transporting ATPase 3, transcript variant X6
plasma membrane calcium-transporting ATPase 3, transcript variant X8
plasma membrane calcium-transporting ATPase 3, transcript variant X16
plasma membrane calcium-transporting ATPase 3, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
plasma membrane calcium-transporting ATPase 3, transcript variant X17
plasma membrane calcium-transporting ATPase 3, transcript variant X5
plasma membrane calcium-transporting ATPase 2 isoform X1
plasma membrane calcium-transporting ATPase 2 isoform X7
plasma membrane calcium-transporting ATPase 2 isoform X3
plasma membrane calcium-transporting ATPase 2 isoform X5
plasma membrane calcium-transporting ATPase 2 isoform X6
plasma membrane calcium-transporting ATPase 2 isoform X2
plasma membrane calcium-transporting ATPase 2 isoform X12
plasma membrane calcium-transporting ATPase 2 isoform X4
plasma membrane calcium-transporting ATPase 3 isoform X9
plasma membrane calcium-transporting ATPase 3 isoform X10
plasma membrane calcium-transporting ATPase 3 isoform X8
plasma membrane calcium-transporting ATPase 3 isoform X13
plasma membrane calcium-transporting ATPase 3 isoform X11
transcriptional regulator ATRX-like, transcript variant X2
transcriptional regulator ATRX-like, transcript variant X1
transcriptional regulator ATRX-like isoform X2
transcriptional regulator ATRX-like isoform X1
uncharacterized LOC125059132, transcript variant X1
uncharacterized LOC125059132, transcript variant X2
uncharacterized protein LOC125059132 isoform X1
uncharacterized protein LOC125059132 isoform X2
protein lethal(2)essential for life-like
tyrosine-protein phosphatase 69D, transcript variant X4
tyrosine-protein phosphatase 69D, transcript variant X2
tyrosine-protein phosphatase 69D, transcript variant X3
tyrosine-protein phosphatase 69D, transcript variant X1
tyrosine-protein phosphatase 69D isoform X4
tyrosine-protein phosphatase 69D isoform X2
tyrosine-protein phosphatase 69D isoform X3
tyrosine-protein phosphatase 69D isoform X1
uncharacterized LOC125059416, transcript variant X1
uncharacterized LOC125059416, transcript variant X2
uncharacterized protein LOC125059416 isoform X1
uncharacterized protein LOC125059416 isoform X2
transfer RNA arginine (anticodon ACG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC125059229, transcript variant X2
uncharacterized LOC125059229, transcript variant X1
uncharacterized protein LOC125059229 isoform X2
uncharacterized protein LOC125059229 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
dual specificity protein phosphatase MPK-4-like
transcriptional activator cubitus interruptus, transcript variant X2
transcriptional activator cubitus interruptus, transcript variant X1
transcriptional activator cubitus interruptus isoform X2
transcriptional activator cubitus interruptus isoform X1
facilitated trehalose transporter Tret1-like, transcript variant X2
facilitated trehalose transporter Tret1-like, transcript variant X1
facilitated trehalose transporter Tret1-like isoform X1
facilitated trehalose transporter Tret1-like isoform X2
histone lysine demethylase PHF8-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
histone lysine demethylase PHF8-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 93 samples with support for all annotated introns
facilitated trehalose transporter Tret1-like
Na(+)/H(+) exchange regulatory cofactor NHE-RF2
epidermal growth factor receptor kinase substrate 8-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
epidermal growth factor receptor kinase substrate 8-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 73 samples with support for all annotated introns
epidermal growth factor receptor kinase substrate 8-like isoform X1
epidermal growth factor receptor kinase substrate 8-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 165 samples with support for all annotated introns
zinc finger protein 239-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc finger protein 239-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 61 samples with support for all annotated introns
transcriptional activator protein Pur-alpha, transcript variant X1
transcriptional activator protein Pur-alpha, transcript variant X2
transcriptional activator protein Pur-alpha isoform X1
transcriptional activator protein Pur-alpha isoform X2
transcriptional activator protein Pur-alpha, transcript variant X3
transcriptional activator protein Pur-beta isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
facilitated trehalose transporter Tret1-2 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC125059149, transcript variant X1
uncharacterized LOC125059149, transcript variant X2
uncharacterized protein LOC125059149 isoform X1
uncharacterized protein LOC125059149 isoform X2
chloride channel protein 2, transcript variant X2
chloride channel protein 2, transcript variant X1
transfer RNA serine (anticodon GCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 102 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
forkhead box protein P1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
forkhead box protein P1, transcript variant X2
forkhead box protein P1, transcript variant X4
forkhead box protein P1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
forkhead box protein P1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
uncharacterized LOC125059206, transcript variant X1
uncharacterized LOC125059206, transcript variant X2
uncharacterized protein LOC125059206 isoform X1
uncharacterized protein LOC125059206 isoform X2
LIM domain and actin-binding protein 1, transcript variant X1
LIM domain and actin-binding protein 1, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
myb/SANT-like DNA-binding domain-containing protein 3
calcium-dependent secretion activator, transcript variant X3
calcium-dependent secretion activator, transcript variant X12
calcium-dependent secretion activator, transcript variant X11
calcium-dependent secretion activator, transcript variant X4
calcium-dependent secretion activator, transcript variant X2
calcium-dependent secretion activator, transcript variant X9
calcium-dependent secretion activator, transcript variant X10
calcium-dependent secretion activator, transcript variant X5
calcium-dependent secretion activator, transcript variant X7
calcium-dependent secretion activator, transcript variant X6
calcium-dependent secretion activator, transcript variant X1
calcium-dependent secretion activator, transcript variant X8
calcium-dependent secretion activator isoform X3
calcium-dependent secretion activator isoform X12
calcium-dependent secretion activator isoform X11
calcium-dependent secretion activator isoform X4
calcium-dependent secretion activator isoform X2
calcium-dependent secretion activator isoform X9
calcium-dependent secretion activator isoform X10
calcium-dependent secretion activator isoform X5
calcium-dependent secretion activator isoform X7
calcium-dependent secretion activator isoform X6
calcium-dependent secretion activator isoform X1
calcium-dependent secretion activator isoform X8
MAM and LDL-receptor class A domain-containing protein 1-like, transcript variant X2
MAM and LDL-receptor class A domain-containing protein 1-like, transcript variant X1
MAM and LDL-receptor class A domain-containing protein 1-like isoform X2
MAM and LDL-receptor class A domain-containing protein 1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 84 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
zinc finger protein 879-like, transcript variant X2
zinc finger protein 879-like, transcript variant X3
zinc finger protein 879-like, transcript variant X1
zinc finger protein 879-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
zinc finger protein 879-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
zinc finger protein 879-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
zinc finger protein 879-like, transcript variant X7
zinc finger protein 879-like, transcript variant X9
zinc finger protein 879-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 85 samples with support for all annotated introns
zinc finger protein 879-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 99 samples with support for all annotated introns
GDNF-inducible zinc finger protein 1-like isoform X6
GDNF-inducible zinc finger protein 1-like isoform X5
GDNF-inducible zinc finger protein 1-like isoform X7
uncharacterized protein LOC125059060 isoform X4
uncharacterized protein LOC125059060 isoform X1
uncharacterized protein LOC125059060 isoform X2
uncharacterized protein LOC125059060 isoform X3
sodium- and chloride-dependent GABA transporter 1, transcript variant X2
sodium- and chloride-dependent GABA transporter 1, transcript variant X1
sodium- and chloride-dependent GABA transporter 1
NACHT and WD repeat domain-containing protein 2
solute carrier family 12 member 9, transcript variant X3
solute carrier family 12 member 9, transcript variant X1
solute carrier family 12 member 9, transcript variant X2
solute carrier family 12 member 9 isoform X2
solute carrier family 12 member 9 isoform X1
solute carrier family 12 member 9 isoform X3
probable small nuclear ribonucleoprotein G
transcription factor EB, transcript variant X1
transcription factor EB, transcript variant X3
transcription factor EB, transcript variant X2
transcription factor EB, transcript variant X5
transcription factor EB, transcript variant X4
transcription factor EB, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
uncharacterized LOC125059152, transcript variant X4
uncharacterized LOC125059152, transcript variant X5
uncharacterized LOC125059152, transcript variant X1
uncharacterized LOC125059152, transcript variant X6
uncharacterized LOC125059152, transcript variant X2
uncharacterized LOC125059152, transcript variant X7
uncharacterized LOC125059152, transcript variant X3
uncharacterized LOC125059152, transcript variant X8
uncharacterized LOC125059152, transcript variant X9
uncharacterized LOC125059152, transcript variant X11
uncharacterized LOC125059152, transcript variant X10
uncharacterized protein LOC125059152 isoform X4
uncharacterized protein LOC125059152 isoform X2
uncharacterized protein LOC125059152 isoform X3
uncharacterized protein LOC125059152 isoform X1
guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1
ATP-binding cassette sub-family D member, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 164 samples with support for all annotated introns
ATP-binding cassette sub-family D member, transcript variant X2
ATP-binding cassette sub-family D member
IQ motif and SEC7 domain-containing protein 1, transcript variant X6
IQ motif and SEC7 domain-containing protein 1, transcript variant X1
IQ motif and SEC7 domain-containing protein 1, transcript variant X3
IQ motif and SEC7 domain-containing protein 1, transcript variant X7
IQ motif and SEC7 domain-containing protein 1, transcript variant X2
IQ motif and SEC7 domain-containing protein 3 isoform X1
IQ motif and SEC7 domain-containing protein 3 isoform X2
IQ motif and SEC7 domain-containing protein 2 isoform X5
IQ motif and SEC7 domain-containing protein 3 isoform X4
IQ motif and SEC7 domain-containing protein 1, transcript variant X4
IQ motif and SEC7 domain-containing protein 1, transcript variant X8
IQ motif and SEC7 domain-containing protein 1, transcript variant X5
IQ motif and SEC7 domain-containing protein 2 isoform X3
IQ motif and SEC7 domain-containing protein 1 isoform X6
fat-like cadherin-related tumor suppressor homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
fat-like cadherin-related tumor suppressor homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
fat-like cadherin-related tumor suppressor homolog isoform X2
fat-like cadherin-related tumor suppressor homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
uncharacterized LOC125059424, transcript variant X2
uncharacterized LOC125059424, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC125059421, transcript variant X2
uncharacterized protein LOC125059421 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC125059421, transcript variant X1
uncharacterized protein LOC125059421 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 69 samples with support for all annotated introns
protein O-mannosyl-transferase TMTC1-like
serine protease inhibitor Kazal-type 5-like, transcript variant X1
serine protease inhibitor Kazal-type 5-like, transcript variant X2
serine protease inhibitor Kazal-type 5-like, transcript variant X3
serine protease inhibitor Kazal-type 5-like, transcript variant X4
serine protease inhibitor Kazal-type 5-like isoform X4
serine protease inhibitor Kazal-type 5-like isoform X3
serine protease inhibitor dipetalogastin-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
beta-1,4-glucuronyltransferase 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
helicase POLQ-like, transcript variant X1
helicase POLQ-like, transcript variant X2
helicase POLQ-like, transcript variant X3
troponin T, skeletal muscle, transcript variant X2
troponin T, skeletal muscle, transcript variant X1
troponin T, skeletal muscle, transcript variant X3
troponin T, skeletal muscle, transcript variant X5
troponin T, skeletal muscle, transcript variant X4
troponin T, skeletal muscle, transcript variant X6
troponin T, skeletal muscle, transcript variant X7
troponin T, skeletal muscle, transcript variant X8
troponin T, skeletal muscle, transcript variant X10
troponin T, skeletal muscle, transcript variant X9
coatomer subunit beta, transcript variant X1
coatomer subunit beta, transcript variant X2
coatomer subunit beta, transcript variant X4
coatomer subunit beta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
probable U3 small nucleolar RNA-associated protein 11
uncharacterized LOC125059185, transcript variant X2
uncharacterized LOC125059185, transcript variant X1
uncharacterized protein LOC125059185 isoform X2
uncharacterized protein LOC125059185 isoform X1
uncharacterized LOC125059185, transcript variant X3
uncharacterized protein LOC125059185 isoform X3
glycine N-methyltransferase, transcript variant X1
glycine N-methyltransferase, transcript variant X2
protein transport protein Sec61 subunit gamma, transcript variant X1
protein transport protein Sec61 subunit gamma, transcript variant X2
protein transport protein Sec61 subunit gamma
exocyst complex component 7, transcript variant X2
exocyst complex component 7, transcript variant X1
uncharacterized LOC125059231, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 156 samples with support for all annotated introns
uncharacterized LOC125059231, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 135 samples with support for all annotated introns
uncharacterized LOC125059231, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 101 samples with support for all annotated introns
uncharacterized LOC125059231, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
uncharacterized LOC125059231, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 61 samples with support for all annotated introns
uncharacterized protein LOC125059231 isoform X2
uncharacterized LOC125059231, transcript variant X1
uncharacterized protein LOC125059231 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 87 samples with support for all annotated introns
sugar transporter ERD6-like 2, transcript variant X2
sugar transporter ERD6-like 2, transcript variant X1
sugar transporter ERD6-like 2 isoform X2
sugar transporter ERD6-like 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125059307, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
uncharacterized LOC125059307, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 84 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized LOC125059365, transcript variant X1
uncharacterized LOC125059365, transcript variant X4
uncharacterized LOC125059365, transcript variant X5
uncharacterized LOC125059365, transcript variant X3
uncharacterized LOC125059365, transcript variant X2
uncharacterized protein LOC125059365 isoform X2
uncharacterized protein LOC125059365 isoform X3
uncharacterized protein LOC125059365 isoform X4
uncharacterized protein LOC125059365 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 112 samples with support for all annotated introns
V-type proton ATPase 16 kDa proteolipid subunit c
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 138 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
proton-coupled amino acid transporter-like protein CG1139, transcript variant X1
proton-coupled amino acid transporter-like protein CG1139, transcript variant X2
proton-coupled amino acid transporter-like protein CG1139, transcript variant X3
proton-coupled amino acid transporter-like protein CG1139
proton-coupled amino acid transporter-like protein pathetic, transcript variant X2
proton-coupled amino acid transporter-like protein pathetic, transcript variant X1
proton-coupled amino acid transporter-like protein pathetic isoform X2
proton-coupled amino acid transporter-like protein pathetic isoform X1
glycine receptor subunit alpha-4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glycine receptor subunit alpha-4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
glycine receptor subunit alpha-4 isoform X2
glycine receptor subunit alpha-1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
MORN repeat-containing protein 4 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
elongation of very long chain fatty acids protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
proton-coupled amino acid transporter-like protein pathetic
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 124 samples with support for all annotated introns
DNA-binding protein D-ETS-4, transcript variant X2
DNA-binding protein D-ETS-4, transcript variant X1
DNA-binding protein D-ETS-4, transcript variant X4
DNA-binding protein D-ETS-4, transcript variant X3
uncharacterized protein LOC125059248 isoform X22
uncharacterized protein LOC125059248 isoform X21
uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02-like isoform X17
uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02-like isoform X15
uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02-like isoform X14
uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02-like isoform X8
uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02-like isoform X7
uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02-like isoform X18
uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02-like isoform X16
zinc finger protein jing, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 109 samples with support for all annotated introns
zinc finger protein jing, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
SH3 and multiple ankyrin repeat domains protein 3, transcript variant X2
SH3 and multiple ankyrin repeat domains protein 3, transcript variant X1
SH3 and multiple ankyrin repeat domains protein 3, transcript variant X4
SH3 and multiple ankyrin repeat domains protein 3, transcript variant X6
SH3 and multiple ankyrin repeat domains protein 3, transcript variant X7
SH3 and multiple ankyrin repeat domains protein 3, transcript variant X5
SH3 and multiple ankyrin repeat domains protein 3, transcript variant X9
SH3 and multiple ankyrin repeat domains protein 3, transcript variant X8
SH3 and multiple ankyrin repeat domains protein 3, transcript variant X3
SH3 and multiple ankyrin repeat domains protein 3 isoform X1
SH3 and multiple ankyrin repeat domains protein 3 isoform X2
SH3 and multiple ankyrin repeat domains protein 3 isoform X4
SH3 and multiple ankyrin repeat domains protein 3 isoform X5
SH3 and multiple ankyrin repeat domains protein 3 isoform X3
SH3 and multiple ankyrin repeat domains protein 3 isoform X7
SH3 and multiple ankyrin repeat domains protein 3 isoform X6
uncharacterized LOC125059255, transcript variant X2
uncharacterized LOC125059255, transcript variant X1
probable arginine--tRNA ligase, mitochondrial
CREB-binding protein, transcript variant X6
CREB-binding protein, transcript variant X8
CREB-binding protein, transcript variant X5
CREB-binding protein, transcript variant X7
CREB-binding protein, transcript variant X9
CREB-binding protein, transcript variant X1
CREB-binding protein, transcript variant X4
CREB-binding protein, transcript variant X2
CREB-binding protein, transcript variant X3
membrane-associated progesterone receptor component 1
iduronate 2-sulfatase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
iduronate 2-sulfatase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
breast carcinoma-amplified sequence 3 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
breast carcinoma-amplified sequence 3 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 83 samples with support for all annotated introns
breast carcinoma-amplified sequence 3 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
breast carcinoma-amplified sequence 3 homolog isoform X3
uncharacterized protein LOC125059426 isoform X1
uncharacterized protein LOC125059426 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
nose resistant to fluoxetine protein 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 65 samples with support for all annotated introns
protein ALP1-like, transcript variant X1
protein ALP1-like, transcript variant X2
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like isoform X2
uncharacterized LOC125059329, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
uncharacterized LOC125059329, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
uncharacterized protein LOC125059329 isoform X2
uncharacterized protein LOC125059329 isoform X1
membrane-associated progesterone receptor component 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
kinesin-related protein 4-like, transcript variant X1
kinesin-related protein 4-like, transcript variant X2
kinesin-related protein 4-like isoform X1
kinesin-related protein 4-like isoform X2
gem-associated protein 5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
gem-associated protein 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 105 samples with support for all annotated introns
dehydrodolichyl diphosphate synthase complex subunit DHDDS, transcript variant X2
dehydrodolichyl diphosphate synthase complex subunit DHDDS, transcript variant X1
dehydrodolichyl diphosphate synthase complex subunit DHDDS isoform X2
dehydrodolichyl diphosphate synthase complex subunit DHDDS isoform X1
RNA transcription, translation and transport factor protein
mitochondrial import inner membrane translocase subunit Tim8
adenosine deaminase-like protein, transcript variant X3
adenosine deaminase-like protein, transcript variant X1
adenosine deaminase-like protein, transcript variant X2
N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase, transcript variant X2
N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase, transcript variant X1
probable DNA-directed RNA polymerases I and III subunit RPAC2
cytochrome P450 CYP12A2-like, transcript variant X2
cytochrome P450 CYP12A2-like, transcript variant X1
cytochrome P450 CYP12A2-like, transcript variant X3
carboxypeptidase Q-like, transcript variant X1
carboxypeptidase Q-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments
trimethyllysine dioxygenase, mitochondrial-like, transcript variant X2
trimethyllysine dioxygenase, mitochondrial-like, transcript variant X3
trimethyllysine dioxygenase, mitochondrial-like, transcript variant X5
trimethyllysine dioxygenase, mitochondrial-like, transcript variant X4
trimethyllysine dioxygenase, mitochondrial-like, transcript variant X1
trimethyllysine dioxygenase, mitochondrial-like, transcript variant X6
trimethyllysine dioxygenase, mitochondrial-like isoform X2
trimethyllysine dioxygenase, mitochondrial-like isoform X5
trimethyllysine dioxygenase, mitochondrial-like isoform X3
trimethyllysine dioxygenase, mitochondrial-like isoform X4
trimethyllysine dioxygenase, mitochondrial-like isoform X1
trimethyllysine dioxygenase, mitochondrial-like isoform X6
trimethyllysine dioxygenase, mitochondrial-like
venom dipeptidyl peptidase 4-like, transcript variant X2
venom dipeptidyl peptidase 4-like isoform X2
venom dipeptidyl peptidase 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
venom dipeptidyl peptidase 4-like isoform X1
synaptotagmin-5-like, transcript variant X2
synaptotagmin-5-like, transcript variant X1
synaptotagmin-5-like, transcript variant X6
synaptotagmin-5-like, transcript variant X5
synaptotagmin-5-like, transcript variant X3
synaptotagmin-5-like, transcript variant X4
uncharacterized LOC125059004, transcript variant X2
uncharacterized LOC125059004, transcript variant X3
uncharacterized LOC125059004, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
uncharacterized LOC125059004, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 81 samples with support for all annotated introns
uncharacterized LOC125059004, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 162 samples with support for all annotated introns
uncharacterized protein LOC125059004 isoform X2
uncharacterized protein LOC125059004 isoform X3
uncharacterized protein LOC125059004 isoform X1
TBC domain-containing protein kinase-like protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 146 samples with support for all annotated introns
TBC domain-containing protein kinase-like protein, transcript variant X2
TBC domain-containing protein kinase-like protein isoform X1
TBC domain-containing protein kinase-like protein isoform X2
cyclic AMP response element-binding protein A
heparan-alpha-glucosaminide N-acetyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 78 samples with support for all annotated introns
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha isoform X2
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha isoform X1
uncharacterized LOC125059120, transcript variant X3
uncharacterized LOC125059120, transcript variant X4
uncharacterized LOC125059120, transcript variant X1
uncharacterized protein LOC125059120 isoform X1
uncharacterized protein LOC125059120 isoform X4
uncharacterized protein LOC125059120 isoform X3
uncharacterized LOC125059120, transcript variant X2
uncharacterized protein LOC125059120 isoform X2
retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta, transcript variant X1
retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta isoform X1
retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta, transcript variant X2
retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta isoform X2
eukaryotic translation initiation factor 5B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
ATP-dependent RNA helicase SUV3 homolog, mitochondrial
uncharacterized LOC125059219, transcript variant X2
uncharacterized LOC125059219, transcript variant X1
uncharacterized protein LOC125059219 isoform X1
uncharacterized protein LOC125059219 isoform X2
cytochrome P450 4d2-like, transcript variant X2
cytochrome P450 4d2-like, transcript variant X1
39S ribosomal protein L27, mitochondrial
uncharacterized LOC125059394, transcript variant X2
uncharacterized LOC125059394, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 104 samples with support for all annotated introns
lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog
roundabout homolog 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
roundabout homolog 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
uncharacterized LOC125059310, transcript variant X2
uncharacterized LOC125059310, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 4 bases at 4 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC125059043
proton channel OtopLc, transcript variant X4
proton channel OtopLc, transcript variant X6
proton channel OtopLc, transcript variant X7
proton channel OtopLc, transcript variant X1
proton channel OtopLc, transcript variant X8
proton channel OtopLc, transcript variant X5
proton channel OtopLc, transcript variant X3
proton channel OtopLc, transcript variant X2
proton channel OtopLc, transcript variant X9
proton channel OtopLc, transcript variant X10
proton channel OtopLc-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
proton channel OtopLc-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments, including 118 samples with support for all annotated introns
carbonyl reductase [NADPH] 3-like, transcript variant X1
carbonyl reductase [NADPH] 3-like isoform X1
carbonyl reductase [NADPH] 3-like, transcript variant X2
carbonyl reductase [NADPH] 3-like isoform X2
uncharacterized LOC125059146, transcript variant X6
uncharacterized LOC125059146, transcript variant X4
uncharacterized LOC125059146, transcript variant X3
uncharacterized LOC125059146, transcript variant X5
uncharacterized LOC125059146, transcript variant X1
uncharacterized LOC125059146, transcript variant X2
uncharacterized protein LOC125059146 isoform X5
uncharacterized protein LOC125059146 isoform X3
uncharacterized protein LOC125059146 isoform X2
uncharacterized protein LOC125059146 isoform X4
uncharacterized protein LOC125059146 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 106 samples with support for all annotated introns
glycine receptor subunit alpha-4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
glycine receptor subunit alpha-4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC125059247, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
uncharacterized LOC125059247, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 154 samples with support for all annotated introns
endothelin-converting enzyme homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
endothelin-converting enzyme homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 80 samples with support for all annotated introns
endothelin-converting enzyme homolog isoform X2
endothelin-converting enzyme homolog isoform X1
dihydropyrimidinase, transcript variant X1
dihydropyrimidinase, transcript variant X3
dihydropyrimidinase, transcript variant X2
dihydropyrimidinase, transcript variant X4
regulation of nuclear pre-mRNA domain-containing protein 2, transcript variant X3
regulation of nuclear pre-mRNA domain-containing protein 2, transcript variant X2
regulation of nuclear pre-mRNA domain-containing protein 2, transcript variant X1
regulation of nuclear pre-mRNA domain-containing protein 2 isoform X3
uncharacterized protein LOC125059047 isoform X2
regulation of nuclear pre-mRNA domain-containing protein 2 isoform X1
uncharacterized LOC125059012, transcript variant X4
uncharacterized LOC125059012, transcript variant X3
uncharacterized LOC125059012, transcript variant X8
uncharacterized LOC125059012, transcript variant X7
uncharacterized LOC125059012, transcript variant X2
uncharacterized LOC125059012, transcript variant X1
uncharacterized protein LOC125059012 isoform X2
uncharacterized protein LOC125059012 isoform X1
uncharacterized protein LOC125059012 isoform X3
uncharacterized LOC125059012, transcript variant X6
uncharacterized LOC125059012, transcript variant X5
uncharacterized LOC125059012, transcript variant X9
uncharacterized LOC125059012, transcript variant X10
uncharacterized protein LOC125059012 isoform X4
uncharacterized LOC125059053, transcript variant X5
uncharacterized LOC125059053, transcript variant X3
uncharacterized LOC125059053, transcript variant X4
uncharacterized LOC125059053, transcript variant X2
uncharacterized LOC125059053, transcript variant X1
CDK-activating kinase assembly factor MAT1, transcript variant X2
CDK-activating kinase assembly factor MAT1, transcript variant X1
CDK-activating kinase assembly factor MAT1
uncharacterized LOC125059390, transcript variant X1
uncharacterized LOC125059390, transcript variant X2
glucose dehydrogenase [FAD, quinone]-like
glucose dehydrogenase [FAD, quinone]-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glucose dehydrogenase [FAD, quinone]-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glucose dehydrogenase [FAD, quinone]-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glucose dehydrogenase [FAD, quinone]-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
glucose dehydrogenase [FAD, quinone]-like isoform X2
glucose dehydrogenase [FAD, quinone]-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
E3 ubiquitin-protein ligase MARCHF2-like, transcript variant X1
E3 ubiquitin-protein ligase MARCHF2-like, transcript variant X2
E3 ubiquitin-protein ligase MARCHF2-like, transcript variant X3
E3 ubiquitin-protein ligase MARCHF2-like, transcript variant X4
uncharacterized protein LOC125059413 isoform X1
E3 ubiquitin-protein ligase MARCHF2-like isoform X2
E3 ubiquitin-protein ligase MARCHF2-like isoform X3
E3 ubiquitin-protein ligase MARCHF2-like isoform X4
nucleoporin nsp1-like, transcript variant X1
nucleoporin nsp1-like, transcript variant X2
nuclear pore glycoprotein p62-like isoform X2
Down syndrome cell adhesion molecule-like protein Dscam2
glycine-rich cell wall structural protein 1.8-like, transcript variant X1
glycine-rich cell wall structural protein 1.8-like, transcript variant X2
glycine-rich cell wall structural protein 1.8-like isoform X1
heterogeneous nuclear ribonucleoprotein A1-like isoform X2
UDP-glycosyltransferase UGT5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 61 samples with support for all annotated introns
UDP-glycosyltransferase UGT5-like isoform X1
UDP-glycosyltransferase UGT5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 64 samples with support for all annotated introns
UDP-glycosyltransferase UGT5-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
UDP-glycosyltransferase UGT5-like, transcript variant X4
UDP-glycosyltransferase UGT5-like isoform X4
UDP-glycosyltransferase UGT5-like, transcript variant X3
UDP-glucosyltransferase 2-like isoform X3
UDP-glycosyltransferase UGT5-like, transcript variant X5
UDP-glycosyltransferase UGT5-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 76 samples with support for all annotated introns
UDP-glucosyltransferase 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
UDP-glucosyltransferase 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
UDP-glucosyltransferase 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
UDP-glucosyltransferase 2-like isoform X4
UDP-glucosyltransferase 2-like isoform X2
UDP-glucosyltransferase 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 84 samples with support for all annotated introns
UDP-glucosyltransferase 2-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Down syndrome cell adhesion molecule homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
meiosis-specific coiled-coil domain-containing protein MEIOC-like, transcript variant X3
meiosis-specific coiled-coil domain-containing protein MEIOC-like, transcript variant X1
meiosis-specific coiled-coil domain-containing protein MEIOC-like, transcript variant X2
uncharacterized protein LOC125059187 isoform X3
meiosis-specific coiled-coil domain-containing protein MEIOC-like isoform X2
uncharacterized protein LOC125059187 isoform X1
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 141 samples with support for all annotated introns
photoreceptor-specific nuclear receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
photoreceptor-specific nuclear receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
photoreceptor-specific nuclear receptor-like isoform X1
photoreceptor-specific nuclear receptor-like isoform X2
Down syndrome cell adhesion molecule-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X1
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 135 samples with support for all annotated introns
phenoloxidase-activating enzyme-like, transcript variant X1
phenoloxidase-activating enzyme-like, transcript variant X2
phenoloxidase-activating enzyme-like isoform X1
phenoloxidase-activating enzyme-like isoform X2
structural maintenance of chromosomes protein 5, transcript variant X1
structural maintenance of chromosomes protein 5 isoform X1
structural maintenance of chromosomes protein 5, transcript variant X2
structural maintenance of chromosomes protein 5 isoform X2
armadillo repeat-containing protein 6 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
PRKCA-binding protein, transcript variant X2
PRKCA-binding protein, transcript variant X5
PRKCA-binding protein, transcript variant X3
PRKCA-binding protein, transcript variant X7
PRKCA-binding protein, transcript variant X1
PRKCA-binding protein, transcript variant X6
PRKCA-binding protein, transcript variant X4
uncharacterized LOC125059439, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 88 samples with support for all annotated introns
uncharacterized LOC125059439, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
chymotrypsin-like elastase family member 2A
regulator of hypoxia-inducible factor 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 164 samples with support for all annotated introns
urokinase-type plasminogen activator-like
cleavage and polyadenylation specificity factor subunit 1
MIP18 family protein galla-1, transcript variant X1
autophagy-related protein 13 homolog isoform X1
MIP18 family protein galla-1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
40S ribosomal protein S11, transcript variant X2
40S ribosomal protein S11, transcript variant X1
golgin subfamily A member 4, transcript variant X1
golgin subfamily A member 4, transcript variant X2
golgin subfamily A member 4, transcript variant X3
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
insulin gene enhancer protein ISL-1, transcript variant X1
insulin gene enhancer protein ISL-1, transcript variant X2
insulin gene enhancer protein ISL-1 isoform X1
insulin gene enhancer protein ISL-1 isoform X2
endoplasmic reticulum metallopeptidase 1-like, transcript variant X1
endoplasmic reticulum metallopeptidase 1-like, transcript variant X2
endoplasmic reticulum metallopeptidase 1-like, transcript variant X5
endoplasmic reticulum metallopeptidase 1-like, transcript variant X7
endoplasmic reticulum metallopeptidase 1-like, transcript variant X4
endoplasmic reticulum metallopeptidase 1-like, transcript variant X8
endoplasmic reticulum metallopeptidase 1-like isoform X1
endoplasmic reticulum metallopeptidase 1-like isoform X2
endoplasmic reticulum metallopeptidase 1-like isoform X4
endoplasmic reticulum metallopeptidase 1-like isoform X8
endoplasmic reticulum metallopeptidase 1-like, transcript variant X3
endoplasmic reticulum metallopeptidase 1-like, transcript variant X6
endoplasmic reticulum metallopeptidase 1-like isoform X3
endoplasmic reticulum metallopeptidase 1-like isoform X6
endoplasmic reticulum metallopeptidase 1-like isoform X5
endoplasmic reticulum metallopeptidase 1-like isoform X7
zinc finger CCCH domain-containing protein 13-like, transcript variant X2
zinc finger CCCH domain-containing protein 13-like, transcript variant X1
uncharacterized protein LOC125059174 isoform X2
zinc finger CCCH domain-containing protein 13-like isoform X1
hyaluronidase-like, transcript variant X1
hyaluronidase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 69 samples with support for all annotated introns
G protein-activated inward rectifier potassium channel 3-like
ATP-sensitive inward rectifier potassium channel 11-like
uncharacterized LOC125059025, transcript variant X3
uncharacterized LOC125059025, transcript variant X1
uncharacterized LOC125059025, transcript variant X2
uncharacterized protein LOC125059025 isoform X3
uncharacterized protein LOC125059025 isoform X1
uncharacterized protein LOC125059025 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 131 samples with support for all annotated introns
hydroxylysine kinase, transcript variant X2
hydroxylysine kinase, transcript variant X1
doublesex- and mab-3-related transcription factor A2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
RNA-binding protein 5-A-like, transcript variant X3
RNA-binding protein 5-A-like, transcript variant X1
RNA-binding protein 5-A-like, transcript variant X2
uncharacterized LOC125059112, transcript variant X2
uncharacterized LOC125059112, transcript variant X1
uncharacterized protein LOC125059112 isoform X1
uncharacterized protein LOC125059112 isoform X2
juvenile hormone esterase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
juvenile hormone esterase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 82 samples with support for all annotated introns
juvenile hormone esterase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 77 samples with support for all annotated introns
juvenile hormone esterase-like isoform X3
juvenile hormone esterase-like isoform X2
juvenile hormone esterase-like isoform X1
nematocyst expressed protein 4-like, transcript variant X2
nematocyst expressed protein 4-like isoform X2
nematocyst expressed protein 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
MAPK-interacting and spindle-stabilizing protein-like isoform X1
39S ribosomal protein L54, mitochondrial
outer dense fiber protein 3-like protein 2
chromaffin granule amine transporter-like
pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1